166 related articles for article (PubMed ID: 21181022)
21. The Enhanced Liver Fibrosis Index Predicts Hepatic Fibrosis Superior to FIB4 and APRI in HIV/HCV Infected Patients.
Abdel-Hameed EA; Rouster SD; Kottilil S; Sherman KE
Clin Infect Dis; 2021 Aug; 73(3):450-459. PubMed ID: 32459305
[TBL] [Abstract][Full Text] [Related]
22. Transient elastography: a non-invasive tool for assessing liver fibrosis in HIV/HCV patients.
Li Vecchi V; Soresi M; Colomba C; Mazzola G; Colletti P; Mineo M; Di Carlo P; La Spada E; Vizzini G; Montalto G
World J Gastroenterol; 2010 Nov; 16(41):5225-32. PubMed ID: 21049556
[TBL] [Abstract][Full Text] [Related]
23. Coinfection with hepatitis C virus, oxidative stress and antioxidant status in HIV-positive drug users in Miami.
Baum MK; Sales S; Jayaweera DT; Lai S; Bradwin G; Rafie C; Page JB; Campa A
HIV Med; 2011 Feb; 12(2):78-86. PubMed ID: 20500231
[TBL] [Abstract][Full Text] [Related]
24. Change in fibrosis score as a predictor of mortality among HIV-infected patients with viral hepatitis.
Jain MK; Seremba E; Bhore R; Dao D; Joshi R; Attar N; Yuan HJ; Lee WM
AIDS Patient Care STDS; 2012 Feb; 26(2):73-80. PubMed ID: 22239101
[TBL] [Abstract][Full Text] [Related]
25. HAART is associated with lower hepatic necroinflammatory activity in HIV-hepatitis C virus-coinfected patients with CD4 cell count of more than 350 cells/microl at the time of liver biopsy.
Pascual-Pareja JF; Caminoa A; Larrauri C; González-García J; Montes ML; Díez J; Grande M; Arribas JR
AIDS; 2009 May; 23(8):971-5. PubMed ID: 19425223
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients.
DallaPiazza M; Amorosa VK; Localio R; Kostman JR; Lo Re V
BMC Infect Dis; 2010 May; 10():116. PubMed ID: 20465840
[TBL] [Abstract][Full Text] [Related]
27. Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study.
Martel-Laferrière V; Nitulescu R; Cox J; Cooper C; Tyndall M; Rouleau D; Walmsley S; Wong L; Klein MB;
BMC Infect Dis; 2017 Jan; 17(1):80. PubMed ID: 28095797
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of hepatic fibrosis in HIV/HCV co-infected individuals in Yaoundé, Cameroon: usefulness of APRI score in resource-constrained settings.
Dobseu R; Nanfack A; Kowo M; Ambada G; Kamgaing R; Chenwi C; Fainguem N; Ka'e A; Ngangoum E; Sosso S; Tchiegang C; Ndjolo A
BMC Infect Dis; 2020 Oct; 20(1):758. PubMed ID: 33059627
[TBL] [Abstract][Full Text] [Related]
29. Documented rapid course of hepatic fibrosis between two biopsies in patients coinfected by HIV and HCV despite high CD4 cell count.
Bonnard P; Lescure FX; Amiel C; Guiard-Schmid JB; Callard P; Gharakhanian S; Pialoux G
J Viral Hepat; 2007 Nov; 14(11):806-11. PubMed ID: 17927617
[TBL] [Abstract][Full Text] [Related]
30. Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration.
Castera L; Winnock M; Pambrun E; Paradis V; Perez P; Loko MA; Asselineau J; Dabis F; Degos F; Salmon D
HIV Med; 2014 Jan; 15(1):30-9. PubMed ID: 24007567
[TBL] [Abstract][Full Text] [Related]
31. Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy.
de Lédinghen V; Barreiro P; Foucher J; Labarga P; Castéra L; Vispo ME; Bernard PH; Martin-Carbonero L; Neau D; García-Gascó P; Merrouche W; Soriano V
J Viral Hepat; 2008 Jun; 15(6):427-33. PubMed ID: 18221303
[TBL] [Abstract][Full Text] [Related]
32. Enhanced liver fibrosis marker as a noninvasive predictor of mortality in HIV/hepatitis C virus-coinfected women from a multicenter study of women with or at risk for HIV.
Peters MG; Bacchetti P; Boylan R; French AL; Tien PC; Plankey MW; Glesby MJ; Augenbraun M; Golub ET; Karim R; Parkes J; Rosenberg W
AIDS; 2016 Mar; 30(5):723-9. PubMed ID: 26595542
[TBL] [Abstract][Full Text] [Related]
33. Fibrosis Progression in Paired Liver Biopsies from HIV/HCV-Coinfected Patients without Prior Treatment of Hepatitis C.
Leite AG; Duarte MI; Mendes-Correa MC
J Int Assoc Provid AIDS Care; 2015; 14(5):463-8. PubMed ID: 26056147
[TBL] [Abstract][Full Text] [Related]
34. Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients.
Loko MA; Bani-Sadr F; Winnock M; Lacombe K; Carrieri P; Neau D; Morlat P; Serfaty L; Dabis F; Salmon D;
J Viral Hepat; 2011 Jul; 18(7):e307-14. PubMed ID: 21692942
[TBL] [Abstract][Full Text] [Related]
35. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis.
Lin ZH; Xin YN; Dong QJ; Wang Q; Jiang XJ; Zhan SH; Sun Y; Xuan SY
Hepatology; 2011 Mar; 53(3):726-36. PubMed ID: 21319189
[TBL] [Abstract][Full Text] [Related]
36. There is no difference in hepatic fibrosis rates of patients infected with hepatitis C virus and those co-infected with HIV.
Souza AR; Tovo CV; Mattos AA; Chaves S
Braz J Med Biol Res; 2008 Mar; 41(3):223-8. PubMed ID: 18176724
[TBL] [Abstract][Full Text] [Related]
37. High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262).
Nguyen Truong T; Laureillard D; Lacombe K; Duong Thi H; Pham Thi Hanh P; Truong Thi Xuan L; Chu Thi N; Luong Que A; Vu Hai V; Nagot N; Tuaillon E; Dominguez S; Lemoine M
PLoS One; 2016; 11(5):e0153744. PubMed ID: 27148964
[TBL] [Abstract][Full Text] [Related]
38. Progression of liver fibrosis in monoinfected patients by hepatitis C virus and coinfected by HCV and human immunodeficiency virus.
Tovo CV; Becker SC; Almeida PR; Galperim B; Chaves S
Arq Gastroenterol; 2013; 50(1):19-22. PubMed ID: 23657302
[TBL] [Abstract][Full Text] [Related]
39. HAART and liver: is it safe?
Antonello VS; Kliemann DA; Rigel Santos B; Tovo CV
J Infect Dev Ctries; 2014 Nov; 8(11):1444-50. PubMed ID: 25390056
[TBL] [Abstract][Full Text] [Related]
40. Changes in biomarkers of liver disease during successful combination antiretroviral therapy in HIV-HCV-coinfected individuals.
Rohrbach J; Stickel F; Schmid P; Thormann W; Kovari H; Scherrer A; Günthard HF; Vuichard D; Cavassini M; Ambrosioni J; Bernasconi E; Furrer H; Rauch A;
Antivir Ther; 2014; 19(2):149-59. PubMed ID: 24036684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
